RUNX2 and breast cancer: The RT-qPCR analysis demonstrated that ES BC, particularly in its set form, had a stronger stimulatory effect on osteogenic markers (ALPL, RUNX2, COL1A1) than on cementogenic markers (CAP, CP23, CEMP1).